We are live on ! Find out more
INVA icon

Innoviva

308 hedge funds and large institutions have $1.7B invested in Innoviva in 2026 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 132 increasing their positions, 84 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,382% more call options, than puts

Call options by funds: $493K | Put options by funds: $11K

124% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 21

57% more repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 84

8% more funds holding

Funds holding: 286308 (+22)

0.65% less ownership

Funds ownership: 101.99%101.34% (-0.65%)

3% less capital invested

Capital invested by funds: $1.76B → $1.7B (-$60.8M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
308
Holders Change
+22
Holders Change %
+7.69%
% of All Funds
3.71%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
47
Increased
132
Reduced
84
Closed
21
Calls
$493K
Puts
$11K
Net Calls
+$482K
Net Calls Change
-$534K

INVA Hedge Fund Activity: Q2 2026 in Review

308 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2026, worth a combined $1.7B — down 3.5% from $1.76B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new INVA positions and 21 closed out — a net gain of 26 holders — while 132 added to existing stakes and 84 trimmed.

The largest buyer was Bridgeway Capital Management, adding an estimated $7.46M. The largest seller was Arrowstreet Capital, cutting an estimated $35.4M.

  • 308 institutional investors held Innoviva (INVA) as of Q2 2026, up from 286 in Q1 2026.
  • Funds reported $1.7B of Innoviva stock for Q2 2026, down 3.5% quarter-over-quarter.
  • 47 funds opened new Innoviva positions in Q2 2026 and 21 closed out, a net change of +26 holders.
  • The largest Innoviva buyer in Q2 2026 was Bridgeway Capital Management, an estimated $7.46M added.
  • The largest Innoviva seller in Q2 2026 was Arrowstreet Capital, an estimated $35.4M sold.

Based on aggregated 13F filings for Q2 2026.